AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 302 min read$GL

Skarjune Dolores L sold $331K of GL

Skarjune Dolores L (EVP and Chief Admin. Officer) sold 1,850 shares of GLOBE LIFE INC. (GL) at $179.18 ($0.33M total) on 2026-06-30.

Original reporting
SEC EDGAR · Skarjune Dolores L
Published Jun 30, 2026, 4:48 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 4:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$GL
Neutral
medium confidence
Mentioned
$GL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GLNeutralLow
01

Why it matters

This provides a fresh, primary datapoint on insider selling activity, but it does not include any new operational, financial, or regulatory development for the company.

02

Market read

Traders may monitor insider activity for sentiment, but this single open-market sale is unlikely to drive a major repricing without corroborating catalysts.

03

What to watch

No information is provided on whether this is part of a broader pattern of sales, option exercises, or tax planning; without that, the signal is weak.

Relevance 4/10Novelty 5/10Timing: filed same day as the sale (2026-06-30)

Background

The article is an SEC Form 4 insider transaction disclosure for Globe Life (GL).

Company-level read

Ticker impact

$GLNeutralMedium confidence
Context

SEC Form 4 shows EVP and Chief Admin. Officer Skarjune Dolores L sold 1,850 shares of Globe Life at $179.18 on 2026-06-30.

Expected impact

Low likelihood of a sustained price move solely from this single Form 4 sale.

Evidence & confidence

The filing is a disclosed transaction (primary-source) but it is not a buy, not tied to new company fundamentals, and the article provides no additional catalysts beyond the sale mechanics.

Market effects

Sector

Minimal; insider-sale disclosures rarely change sector expectations without accompanying fundamental/regulatory news.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be purely liquidity/tax-driven under a non-10b5-1 arrangement, so it may not reflect bearish views on the business.

Key entities

  • issuer
    Globe Life Inc.

    Subject of the Form 4 insider transaction disclosure (EVP and Chief Admin. Officer sale).

  • insider
    Skarjune Dolores L

    EVP and Chief Admin. Officer who sold 1,850 shares on 2026-06-30.

Read at source← All news

Related articles

JUL 25
$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

sekbernews.id4 min
JUL 23
$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

financialcontent.com6 min
JUL 23
$GLMedAI 8/10

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

benzinga.com10 min
JUL 23
$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

finance.yahoo.com6 min
JUL 23
$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

investing.com4 min
JUL 22
$GLMed

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with

SEC EDGAR 8-K6 min